Perrigo Rating Lowered to Sell at Jefferson Research (PRGO)
Perrigo (NASDAQ:PRGO) was downgraded by analysts at Jefferson Research from a “buy” rating to a “sell” rating in a research report issued to clients and investors on Friday, StockRatingsNetwork.com reports.
Perrigo (NASDAQ:PRGO) traded down 0.40% on Friday, hitting $150.16. The stock had a trading volume of 117,488 shares. Perrigo has a one year low of $112.05 and a one year high of $162.35. The stock’s 50-day moving average is $154.0 and its 200-day moving average is $139.6. The company has a market cap of $20.083 billion and a P/E ratio of 56.38.
Perrigo (NASDAQ:PRGO) last released its earnings data on Thursday, February 6th. The company reported $1.87 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.59 by $0.28. The company had revenue of $979.00 million for the quarter, compared to the consensus estimate of $996.68 million. During the same quarter last year, the company posted $1.36 earnings per share. Perrigo’s revenue was up 10.9% compared to the same quarter last year. Analysts expect that Perrigo will post $6.60 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, March 18th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.105 per share. This represents a $0.42 annualized dividend and a dividend yield of 0.28%. The ex-dividend date is Wednesday, February 26th.
PRGO has been the subject of a number of other recent research reports. Analysts at Argus reiterated a “sell” rating on shares of Perrigo in a research note on Tuesday. They now have a $147.32 price target on the stock, down previously from $175.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Perrigo in a research note on Friday, February 7th. They now have a $154.00 price target on the stock. Finally, analysts at B. Riley downgraded shares of Perrigo from a “buy” rating to a “neutral” rating in a research note on Friday, February 7th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $150.13.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.